OMA Guidelines Bundle

Chronic Disease of Obesity - Obesity Algorithm 2024

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349818

Contents of this Issue

Navigation

Page 10 of 29

11 Measurements BMI in kilograms per meters squared (kg/m 2 ) a Normal Weight 18.5–24.9 Overweight 25.0–29.9 Class I Obesity 30.0–34.9 Class II Obesity 35.0–39.9 Class III Obesity ≥40 Obesity Classification: WC b Abdominal Obesity – Women ≥35 inches ≥88 centimeters Abdominal Obesity – Men ≥40 inches ≥102 centimeters Classification of Percent Body Fat in Adults as Assessed by DXA Women Men Essential fat <15% <10% Athlete 15–19% 10–14% Fitness 20–24% 15–19% Acceptable 25–29% 20–24% Pre-obesity 30–34% 25–29% Obesity ≥35% ≥30% a Different BMI cut-off points may be more appropriate based upon gender, race, ethnicity, and menopausal status. For example, among Asians, a BMI >23 kg/m 2 may indicate pre-obesity, a BMI >27.5 kg/m 2 may indicate class I obesity, a BMI >32.5 kg/m 2 may indicate class II obesity, and a BMI >37.5 kg/m 2 may indicate class III obesity. b A waist to height ratio of 0.5 may be a simplified threshold common to all ethnicities. It may also be a better screening tool for cardiometabolic risk than BMI. Edmonton Obesity Staging System STAGE 0: No apparent risk factors, no physical symptoms, functional limitations, and/ or impairment of well-being STAGE 1: Presence of obesity-related subclinical risk factors, mild physical symptoms, mild psychopathology, mild functional limitations, and/or mild impairment of well-being STAGE 2: Presence of established obesity-related chronic disease, moderate psychopathology, moderate functional limitations, and impairment of wellbeing. STAGE 3: Established end-organ damage, significant psychopathology, significant functional limitations, and/or impairment of well-being. STAGE 4: Severe (potentially end-stage) disabilities from obesity-related chronic diseases, severe disabling psychopathology, severe functional limitations, and/or severe impairment of well-being.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Chronic Disease of Obesity - Obesity Algorithm 2024